Bone marrow transplantation for severe aplastic anemia secondary to temozolomide

Journal of Neuro-Oncology

Volumn 91, Issue 2, 2009, Pages 237-239

  Morris, E Brannon ^a   Kasow, Kimberly ^a   Reiss, Ulrike ^a   Ellison, David ^a   Broniscer, Alberto ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

A plastic anemia; Bone marrow transplant; Myelo suppression; Temozolomide

Indexed keywords

CHELATING AGENT; COLONY STIMULATING FACTOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GENE PRODUCT; GLIAL FIBRILLARY ACIDIC PROTEIN; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TEMOZOLOMIDE; THYMOCYTE ANTIBODY;

ADOLESCENT; ANUS FISSURE; APLASTIC ANEMIA; ARTERIOVENOUS MALFORMATION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; BRAIN BIOPSY; BRAIN HEMORRHAGE; BRAIN NECROSIS; BURNING SENSATION; CANCER GRADING; CANCER RADIOTHERAPY; CAPILLARY RESISTANCE; CASE REPORT; CELL DIFFERENTIATION; CHELATION THERAPY; CHIMERA; CHROMOSOME 7; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; FRONTAL LOBE; GENERAL CONDITION DETERIORATION; GLIOBLASTOMA; GLIOMA; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON OVERLOAD; NEUTROPENIA; NEUTROPHIL COUNT; PANCYTOPENIA; PARIETAL LOBE; PROTEIN EXPRESSION; SIDE EFFECT; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ANEMIA, APLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW TRANSPLANTATION; DACARBAZINE; FEMALE; GLIOMA; HUMANS;

EID: 57349199418     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9704-4     Document Type: Article

References (11)

1. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996. doi: 10.1056/NEJMoa043330
2. Hoang-Xuan K, Capelle L, Kujas M et al (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22(15):3133-3138. doi: 10.1200/JCO.2004.10.169
3. Quinn JA, Reardon DA, Friedman AH et al (2003) Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol 21(4):646-651. doi: 10.1200/JCO.2003.01.009
4. Broniscer A, Gururangan S, MacDonald TJ et al (2007) Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: A pediatric brain tumor consortium report. Clin Cancer Res 13(22 Pt 1):6712-6718. doi: 10.1158/ 1078-0432.CCR-07-1016
5. Broniscer A, Chintagumpala M, Fouladi M et al (2006) Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol 76(3):313-319. doi: 10.1007/ s11060-005-7409-5
6. Gururangan S, Fisher MJ, Allen JC et al (2007) Temozolomide in children with progressive low-grade glioma. Neuro oncol 9(2):161-168. doi: 10.1215/15228517-2006-030
7. Kuo DJ, Weiner HL, Wisoff J et al (2003) Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. J Pediatr Hematol Oncol 25(5):372-378. doi: 10.1097/00043426-200305000-00005
8. Doyle TJ, Mikkelsen T, Croteau D et al (2005) Fatal hematologic toxicity with prolonged continuous administration of temozolomide (TMZ) during radiation therapy (RT) in the treatment of newly-diagnosed glioblastoma multiforme (GBM): Report of a phase II trial. J Clin Oncol (Meeting Abstracts) 23(16 suppl):1546
9. Singhal N, Selva-Nayagam S, Brown MP (2007) Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment-case study and review of literature. J Neurooncol 85(2):229-230. doi: 10.1007/s11060-007-9403-6
10. Jalali R, Singh P, Menon H et al (2007) Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide. J Neurooncol 85(1):105-107. doi: 10.1007/s11060-007-9398-z
11. Villano JL, Collins CA, Manasanch EE et al (2006) Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide. Lancet Oncol 7(5):436-438. doi: 10.1016/S1470-2045(06)70696-9